Viridian Therapeutics, Inc. (VRDN) Net Income by Year
Viridian Therapeutics, Inc. reported a net loss of $342.6M in fiscal year 2025. This represents a decrease of 26.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $387.0M net loss. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Viridian Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRDN Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
VRDN Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Viridian Therapeutics, Inc. financials
Frequently Asked Questions
What was Viridian Therapeutics, Inc.'s net income in fiscal year 2025?
Viridian Therapeutics, Inc. reported a net loss of $342.6M in fiscal year 2025.
How fast is Viridian Therapeutics, Inc.'s net income growing?
Viridian Therapeutics, Inc. (VRDN) net income fell by 26.9% year over year, from -$269.9M to -$342.6M in fiscal year 2025.
What is Viridian Therapeutics, Inc.'s net income over the last twelve months?
Viridian Therapeutics, Inc. (VRDN) reported a $387.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Viridian Therapeutics, Inc.'s net income changed over the years?
Across the 13 fiscal years this page covers, Viridian Therapeutics, Inc. (VRDN) net income went from -$2.2M in fiscal year 2013 to -$342.6M in fiscal year 2025.
What was Viridian Therapeutics, Inc.'s net income in the most recent quarter?
Viridian Therapeutics, Inc. (VRDN) reported -$127.1M in net income in Q2 2026. This represents a decrease of 26.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Viridian Therapeutics, Inc. (VRDN) reported on that line in every period on record.